Category: Pharmaceuticals
Gyros Expands Asian Distribution to Singapore
SINGAPORE – Gyros’ nanoliter-scale immunoassay platform is now available to biopharmaceutical companies in Singapore. Gyrolab xP workstation is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, […]
Takeda Unveils New Drug For Hypertension
JAPAN – Takeda Pharmaceutical has launched its latest treatment for hypertension called Azilva, which is to be orally taken once-daily. Discovered by Takeda, azilsartan is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of […]
Volatile market takes toll on Pharmaceuticals and healthcare IPO plans
INDIA – The volatile market condition has affected the fund raising plans of pharmaceutical and healthcare companies with several firms either withdrawing or deferring their initial public offers (IPO). Drug maker Intas Pharmaceuticals became the latest to join the list […]
Band-aid with healing powers to be made available
SINGAPORE – A band-aid with a coating that can help repair wounds may soon hit the market. A patent has been provisionally filed for the local researchers to come up with a patch containing stem-cell material that can hasten the […]
FDA approves Stendra for erectile dysfunction
THE US Food and Drug Administration (FDA) has approved the new drug Stendra to treat the illness that causes problems in the sex lives of 30 million men. It is the first erectile dysfunction drug in a decade. And its […]
Surya Pharmaceutical closes Jammu, Haryana plants
INDIA – Surya Pharmaceutical Ltd, the flagship company of Rs 1,700-crore Surya Corp., has closed two of its units namely Jammu plant, which was still under trial production and one at Panchkula (Haryana) unit. According to the company, it is […]
Ranbaxy unveils India’s anti-malarial drug
INDIA – Ranbaxy launched a new anti-malarial drug called Synriam, which is the first molecule indigenously developed by a private Indian pharmaceutical company. Ranbaxy has invested US$30 million since 2003 to develop this drug. The new drug is priced at […]
Abbott Lifts 2012 Forecast
Abbott Laboratories reported better-than-expected quarterly sales and earnings, fueled by strong demand for its Humira arthritis drug and its wide array of prescription medicines, nutritional products and medical devices. The company earned $1.24 billion, or 78 cents per share, in […]
Nestle to buy Pfizer Nutrition for US$11.9B
Swiss food group Nestle will buy U.S. drugmaker Pfizer’s nutrition business for US$11.85 billion, beating out French rival Danone as both battle to gain preeminence in the lucrative baby food market. Nestle, the world’s biggest packaged food company, was already […]
Pharmatech Associates Hires Chat Kwan to Lead Asian Operations
Pharmatech Associates, a compliance consulting firm serving companies in the pharmaceutical, biotech and medical device industries, has appointed veteran biopharmaceutical executive Chat Kwan as Vice President of Asian Operations. Kwan has been instrumental in developing Pharmatech’s business in China and […]
